CD133-binding agents and uses thereof
Grant
US12595312B2
Kind: B2
Apr 07, 2026
Assignee
The Governing Council of the University of Toronto
Inventors
Jason Moffat, Jarrett Adams, Guohua Pan, Sachdev Sidhu, Rashida Williams, Xiaoyu Zhang, Sheila K. Singh, Parvez Vora, Chitra Venugopal
Abstract
This disclosure is directed to novel CD133-binding agents. The disclosure is also directed to uses of novel CD133-binding agents for detecting CD133-expressing cells and/or quantitating levels of cellular CD133 expression, for targeting CD133-expressing cells, for decreasing levels of CD133 in CD133-expressing cells and for treating or preventing cancer.
CPC Classifications
A61K 2039/505
Filing Date
2021-10-26
Application No.
17511420
Claims
27